Natera, Inc. NTRA

Healthcare — Diagnostics & Research

412.56 3.77 0.92% as of 25 Sep

Market cap: $59.2B
P/E: 0.0×

Follow NTRA

Cash Flow Champion (3y)

Growth Flags show if company had growth for consecutive years

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16
P/E ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
P/S ratio	13.58	11.63	6.58	4.62	13.52	20.62	7.75	3.13	2.41	2.89
P/FCF ratio	287.05	285.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
P/Operating CF	423.90	373.30	(123.61)	(46.69)	(85.65)	(109.99)	(155.66)	(63.03)	(17.95)	(20.69)
P/B ratio	18.29	16.52	9.30	5.37	12.95	16.58	8.41	25.11	19.86	5.76
Price to Tangible BV	26.15	16.67	9.30	5.37	12.95	16.58	8.41	25.11	19.86	5.76
EV/Sales	13.27	11.28	6.10	3.96	12.59	19.38	6.70	3.00	2.43	2.53
EV/EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EV/Operating CF	142.18	141.09	(26.75)	(7.53)	(23.49)	(41.52)	(31.93)	(10.95)	(5.20)	(7.25)
EV/FCF	280.55	276.45	(23.08)	(6.78)	(20.92)	(37.49)	(29.62)	(10.38)	(4.73)	(5.52)
Quick Ratio	3.11	3.73	3.77	3.68	4.73	4.10	2.75	1.94	1.54	1.67
Current Ratio	3.39	4.00	4.10	3.90	4.99	4.33	2.91	2.11	1.71	1.81
Net Debt/EBITDA	3.74	4.65	1.23	1.04	1.30	2.40	2.96	0.33	(0.03)	1.04
Debt/Assets	3.35%	4.84%	25.20%	25.96%	26.72%	27.09%	21.24%	46.06%	57.39%	23.55%
Debt/Equity	0.05	0.07	0.47	0.51	0.51	0.52	0.44	3.84	4.85	0.47
Asset Turnover	1.14	1.09	0.76	0.62	0.58	0.52	0.71	1.07	0.99	0.89
Operating CF/Net income	(1.03)	(0.71)	0.57	0.79	0.71	0.79	0.51	0.55	0.71	0.74
Capex/Depreciation	(3.20)	(2.45)	(1.48)	(2.09)	(2.02)	(1.35)	(0.54)	(0.48)	(1.21)	(3.04)
Interest Coverage	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ROE	(14.32%)	(19.42%)	(59.11%)	(80.62%)	(82.79%)	(60.07%)	(80.31%)	(445.14%)	(208.70%)	(68.90%)
ROA	(10.26%)	(12.28%)	(30.66%)	(41.64%)	(43.50%)	(30.33%)	(29.34%)	(53.09%)	(64.72%)	(42.16%)
ROIC	(27.03%)	(45.18%)	(111.70%)	(199.67%)	(422.60%)	(10,224.90%)	0.00%	0.00%	(285.12%)	(710.26%)
Return on Tangible Assets	(16.05%)	(15.95%)	(40.92%)	(55.12%)	(50.20%)	(32.96%)	(34.05%)	(84.94%)	(131.41%)	(91.22%)
Average Days of Receivables	46.93	67.58	93.83	108.75	71.24	73.34	64.41	88.15	76.77	23.01
Research and Development Expense of Revenue	27.06%	23.82%	29.62%	38.58%	42.24%	25.58%	16.99%	19.93%	23.88%	19.70%
Selling, General and Administrative Expense of Revenue	51.05%	49.58%	57.11%	71.76%	81.70%	77.65%	68.20%	60.11%	74.09%	64.06%
Intangible Assets out of Total Assets	0.21	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue	15.37%	16.17%	17.72%	18.58%	18.42%	12.83%	9.47%	5.51%	5.44%	4.99%
Graham Net Nets	0.03	0.05	0.08	0.14	0.06	0.05	0.09	0.01	(0.02)	0.11
Graham Number	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Yield	(0.67%)	(0.97%)	(6.12%)	(14.47%)	(5.54%)	(2.82%)	(5.37%)	(15.97%)	(27.24%)	(15.56%)
Free Cash Flow Yield	0.35%	0.35%	(4.02%)	(12.65%)	(4.45%)	(2.51%)	(2.92%)	(9.22%)	(21.33%)	(15.85%)
Revenue per Share	16.87	13.61	9.41	8.33	6.91	4.83	4.35	4.45	3.93	4.12
Operating CF per Share	1.57	1.09	(2.15)	(4.38)	(3.70)	(2.25)	(0.91)	(1.22)	(1.83)	(1.44)
Capex per Share	(1.02)	(0.62)	(0.34)	(0.48)	(0.45)	(0.24)	(0.07)	(0.07)	(0.19)	(0.45)
Free Cash Flow per Share	0.56	0.47	(2.49)	(4.87)	(4.15)	(2.49)	(0.98)	(1.29)	(2.02)	(1.88)
Cash per Share	7.87	7.76	7.64	9.13	10.10	9.10	6.34	2.74	2.23	2.85
Shareholders Equity per Share	12.52	9.59	6.66	7.17	7.21	6.00	4.01	0.56	0.48	2.06
Interest Debt per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per Share	12.52	9.59	6.66	7.17	7.21	6.00	4.01	0.56	0.48	2.06
Free Cash Flow	76.11	58.75	(286.15)	(479.20)	(376.27)	(202.12)	(68.41)	(74.46)	(107.69)	(97.19)
Working Capital	1,055.71	1,031.78	951.28	901.32	874.18	663.61	343.29	126.54	75.06	77.70
Capital Expenditures	(139.19)	(76.92)	(39.20)	(47.70)	(41.03)	(19.60)	(4.97)	(3.88)	(9.87)	(23.14)
Net Current Asset Value	811.01	910.51	582.18	523.09	509.96	416.75	219.22	4.51	(8.57)	69.91
EV/EBIT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capex to Sales	0.06	0.05	0.04	0.06	0.07	0.05	0.02	0.02	0.05	0.11
Net Profit Margin	(9.03%)	(11.22%)	(40.16%)	(66.79%)	(75.42%)	(58.76%)	(41.29%)	(49.74%)	(65.65%)	(47.21%)
Price to Operating Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other line items
Depreciation/Fixed assets	0.18	0.19	0.24	0.25	0.31	0.44	0.39	0.33	0.27	0.24
Cash ROIC	(0.90%)	(1.18%)	(17.84%)	(26.65%)	(21.11%)	(14.62%)	(10.28%)	(30.22%)	(47.66%)	(35.06%)
Accounts Receivable Turnover	7.55	5.73	4.14	4.48	6.23	5.93	5.23	4.85	7.29	22.07
Accounts Payable Turnover	23.88	26.99	25.56	15.64	18.04	24.39	15.13	14.37	13.95	14.41
Inventory Turnover	14.36	15.76	15.49	14.64	13.57	12.56	13.48	14.68	18.12	18.69
Average Days of Payables	14.89	18.92	9.28	24.92	31.19	14.51	17.90	32.06	22.30	30.90
Days of Inventory on Hand	30.73	24.24	25.22	28.32	30.85	35.91	25.78	29.97	23.53	17.27
Average Receivables	305.35	296.23	261.34	183.23	100.32	65.96	57.79	53.16	28.74	9.63
Average Payables	34.04	24.96	23.07	29.18	17.65	8.35	11.60	11.56	10.00	9.41
Average Inventory	56.59	42.75	38.08	31.16	23.47	16.21	13.01	11.32	7.71	7.25
Average Assets	2,029.54	1,551.22	1,418.09	1,315.48	1,084.32	757.40	425.41	241.39	212.65	237.96
Average Common Equity	1,453.92	980.37	735.54	679.52	569.77	382.47	155.44	28.79	65.95	145.62

Show all line items

Columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

Natera, Inc. NTRA